Delcath Systems, Inc. (DCTH) stock
DCTHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$19.37−0.50 (-2.52%)
Close on Nov 17, 2026Market cap $672.12MP/E 1937.0Yield –
Delcath Systems r&d expenses
Research and development expenses are spending on new products and technology.
Delcath Systems's R&D Expenses for the twelve months ending Jun 30, 2026 was $37.56M, up 101.2% year over year. For fiscal 2025 it was $29.25M, up 110.8% from the year before. Over ten years it grew 16.3% a year on average. The highest annual figure on record is $29.25M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.25M | +110.8% |
| FY2024 | Dec 31, 2024 | $13.87M | -20.7% |
| FY2023 | Dec 31, 2023 | $17.50M | -5.8% |
| FY2022 | Dec 31, 2022 | $18.58M | +34.9% |
| FY2021 | Dec 31, 2021 | $13.78M | +23.0% |
| FY2020 | Dec 31, 2020 | $11.20M | +18.0% |
| FY2019 | Dec 31, 2019 | $9.49M | -51.7% |
| FY2018 | Dec 31, 2018 | $19.65M | +87.2% |
| FY2017 | Dec 31, 2017 | $10.50M | +24.2% |
| FY2016 | Dec 31, 2016 | $8.45M | +30.2% |
| FY2015 | Dec 31, 2015 | $6.49M | +50.9% |
| FY2014 | Dec 31, 2014 | $4.30M | -66.1% |
| FY2013 | Dec 31, 2013 | $12.69M | -51.6% |
| FY2012 | Dec 31, 2012 | $26.22M | +4.1% |
| FY2011 | Dec 31, 2011 | $25.17M | +43.4% |
| FY2010 | Dec 31, 2010 | $17.56M | +82.2% |
| FY2009 | Dec 31, 2009 | $9.64M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $10.38M | +50.8% |
| Q1 FY2026 | Mar 31, 2026 | $9.82M | +96.2% |
| Q4 FY2025 | Dec 31, 2025 | $9.37M | +221.6% |
| Q3 FY2025 | Sep 30, 2025 | $7.99M | +106.6% |
| Q2 FY2025 | Jun 30, 2025 | $6.88M | +102.8% |
| Q1 FY2025 | Mar 31, 2025 | $5.01M | +35.3% |
| Q4 FY2024 | Dec 31, 2024 | $2.91M | -38.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.87M | -17.1% |
| Q2 FY2024 | Jun 30, 2024 | $3.39M | -4.5% |
| Q1 FY2024 | Mar 31, 2024 | $3.70M | -19.1% |
| Q4 FY2023 | Dec 31, 2023 | $4.71M | +6.3% |
| Q3 FY2023 | Sep 30, 2023 | $4.66M | +14.7% |
| Q2 FY2023 | Jun 30, 2023 | $3.56M | -36.6% |
| Q1 FY2023 | Mar 31, 2023 | $4.58M | +2.1% |
| Q4 FY2022 | Dec 31, 2022 | $4.43M | +22.4% |
| Q3 FY2022 | Sep 30, 2022 | $4.07M | +37.6% |
| Q2 FY2022 | Jun 30, 2022 | $5.61M | +60.3% |
| Q1 FY2022 | Mar 31, 2022 | $4.48M | +20.9% |
| Q4 FY2021 | Dec 31, 2021 | $3.62M | +31.9% |
| Q3 FY2021 | Sep 30, 2021 | $2.96M | -9.4% |
| Q2 FY2021 | Jun 30, 2021 | $3.50M | +57.3% |
| Q1 FY2021 | Mar 31, 2021 | $3.71M | +24.6% |
| Q4 FY2020 | Dec 31, 2020 | $2.74M | +1.6% |
| Q3 FY2020 | Sep 30, 2020 | $3.26M | +83.4% |
| Q2 FY2020 | Jun 30, 2020 | $2.22M | +29.7% |
| Q1 FY2020 | Mar 31, 2020 | $2.97M | -9.8% |
| Q4 FY2019 | Dec 31, 2019 | $2.70M | -53.1% |
| Q3 FY2019 | Sep 30, 2019 | $1.78M | -56.7% |
| Q2 FY2019 | Jun 30, 2019 | $1.71M | -58.1% |
| Q1 FY2019 | Mar 31, 2019 | $3.30M | -42.1% |
| Q4 FY2018 | Dec 31, 2018 | $5.76M | +70.7% |
| Q3 FY2018 | Sep 30, 2018 | $4.11M | +80.2% |
| Q2 FY2018 | Jun 30, 2018 | $4.09M | +62.4% |
| Q1 FY2018 | Mar 31, 2018 | $5.69M | +145.2% |
| Q4 FY2017 | Dec 31, 2017 | $3.38M | +36.5% |
| Q3 FY2017 | Sep 30, 2017 | $2.28M | -15.2% |
| Q2 FY2017 | Jun 30, 2017 | $2.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.47M | – |
| Q3 FY2016 | Sep 30, 2016 | $2.69M | – |
See a number that looks wrong?